Solution
Industries
Resources
About
Beacon Search

Companion Diagnostics: Technologies and Markets

Report Code: BIO077A

Publish Date: Nov 2010

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

 
  • Oncotype Dx, although not FDA-approved, is still a lead product in the breast cancer diagnosis sector.  Oncotype Dx is reimbursed by most insurance companies and therefore enjoys an increase in its sales number every year.  Valued at $170 million in 2010, analysts believe that by 2015, Oncotype Dx for breast cancer risk recurrence and drug regimen may reach $300 million, a compound annual growth rate (CAGR) of 12%.
  • The approval of Selzentry for first time HIV patients is creating new opportunity for the assay Trofile, a companion diagnostic to Selzentry (Celsentri outside U.S.). As a result, Trofile is expected to reach an estimated $34 million by 2015, from $24 million in 2010, a compound annual growth rate (CAGR) of 7.2%.

INTRODUCTION 

STUDY GOALS AND OBJECTIVES
 
This BCC Research report, Companion Diagnostics: Technologies and Markets, provides an overview of the current state of development in the companion diagnostics field, existing products on the market, and detailed analysis of the competitive environments, including new potential markets for current industry trends. The study includes information about significant current players in this field of study, trends, and challenges, and other information affecting assay development in this space of personalized medicine.
 
REASONS FOR DOING THIS STUDY
 
When the human genome project was finally completed in 2003, the idea of testing the specific genetic signature for every human individual became a reality. In addition to the fast development of proteomic approaches and array technology, a new trend in personalized medicine started to evolve as part of the healthcare system. Personalized medicine became more and more embraced by healthcare providers, the pharmaceutical industry and even insurance companies, in an attempt to reduce unnecessary expenses and costs for patients’ treatments. Indeed, a new organization was formed called the Personalized Medicine Coalition (PMC), a nonprofit advocacy group that keeps close track of all the recent developments and propositions in this field. 
 
Companion diagnostics is part of the “personalized medicine revolution.” The field evolved as a continuation of biomarker studies and diagnostics testing. And although this area of industry is still young, it becomes more and more complicated and developed, with a number of successful FDA–approved products. 
 
This study will provide knowledge of the current state of the companion diagnostics industry, new technologies in assay development, and more importantly, will describe potential novel commercial venues in this area of the healthcare industry.
 
SCOPE OF REPORT
 
Personalized medicine is relatively new to the market research report format and provides business tools to evaluate new commercial opportunities in diagnostics and biomarker fields. The geographic scope of this study covers U.S. and global companies, but reliable data outside of the U.S was limited and fragmentary, and therefore not often used. The report identifies major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments. This study describes current products in each area, identifies current market participants and, most importantly, notes the trends that are going to affect further product development in this area. The report also provides information about less–developed sectors of this market, and gives a list of current companies that have new companion diagnostics products in development.
 
METHODOLOGY AND INFORMATION SOURCES
 
Both primary and secondary research methodologies were used in preparing this study. The methodology employed a triangulating approach, which aids in validity. 
 
Initially, a comprehensive and exhaustive search of the literature on assay development and already–marketed products was conducted. These secondary sources included assay development and science–related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis were also conducted.
 
In a second phase, a series of semistructured interviews were conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotech and pharmaceutical companies. Other resources included academics, technology and consulting companies, which were rich sources of data. Subsequent analysis of the documents and interview notes was performed thoroughly.
 
INTENDED AUDIENCE
 
This report is intended for business development professionals, healthcare professionals, entrepreneurs, and other investment groups so that they can fully understand and evaluate a new, less–familiar area of the healthcare and diagnostic industry. It provides companies’ corporate development departments with new insight into competitors’ positions and shows new opportunities otherwise overlooked or less known to the public.
 
ANALYST CREDENTIALS
 
Dr. Marianna Tcherpakov has more than 7 years of experience as a bench scientist specializing in the area of biochemistry, cell biology and industrial assay development. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with this research field’s trends and likely future developments.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Companion Diagnostics: Technologies and Markets175Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW, STRUCTURE AND SIGNIFICANCE OF THE COMPANION DIAGNOSTICS INDUSTRY 51Free
Chapter- 4: COMPANION DIAGNOSTICS INDUSTRY OVERVIEW IN DIFFERENT RESEARCH AREAS89Free
Chapter- 5: MARKET SUMMARY6Free
Chapter- 6: SELECTED COMPANIES OVERVIEW9Free
Chapter- 7: DIRECTORY OF COMPANIES14Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 58

  • Summary Table: U.S. NET SALES OF ONCOTYPE AND TROFILE THROUGH 2015
  • Table 1: PERCENTAGE OF PRODUCTS IN EACH SECTOR OF THE COMPANION DIAGNOSTICS INDUSTRY
  • Table 2: OVERVIEW OF PERSONALIZED MEDICINE PRODUCTS
  • Table 3: PERCENTAGE OF EACH PERSONALIZED MEDICINE PRODUCT CATEGORY IN 2008 AND THEIR FORECAST, 2008 AND 2012
  • Table 4: ESTIMATE FOR COMPANION DIAGNOSTICS TEST MARKET FOR THERAPY SELECTION, THROUGH 2015
  • Table 5: GLOBAL BIOMARKER MARKET
  • Table 6: WORLDWIDE MARKET FOR BIOMARKERS ACCORDING TO RESEARCH AREAS IN 2008
  • Table 7: ESTIMATE FOR MAJOR PLAYERS OF IVD COMPANIES IN 2010
  • Table 8: COMPANION DIAGNOSTICS, ASSOCIATED DRUGS AND REGULATORY APPROVAL STATE
  • Table 9: COMPANION DIAGNOSTICS COST EXAMPLES
  • Table 10: EXAMPLES OF COMPANION DIAGNOSTICS EFFECT ON HEALTHCARE SAVINGS
Sample Report

Recent Reports

Botanical and Plant-derived Drugs: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - BIO022J

The global market for botanical and plant-derived drugs is expected to grow from $38.7 billion in 2025 and is projected to reach $58.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2025 to 2030.

Protein Expression: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO165B

The global market for protein expression is estimated to grow from $4.7 billion in 2025 to reach $7.9 billion by 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 through 2030.

Biological Therapies for Cancer: Technologies and Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO048E

The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.

Cell Therapy Processing: Global Markets and Technologies

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO160B

The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.

Fusion Proteins: Global Market

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO274A

The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.

Top Trending Reports

Global Data Center Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - IFT320A

The global market for data centers is expected to grow from $418.2 billion in 2025 and is projected to reach $691.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

Bioprocess Filtration: Global Markets

Published - Oct 2025 | Publisher - BCC Publishing | Code - MDS043B

The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to reach $15.6 billion by 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.

Contract Manufacturing of Medical Devices: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - MDS039B

The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from 2025 to 2030.

Biological Therapies for Cancer: Technologies and Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO048E

The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.

Immunotherapy Drugs: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - PHM249B

The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Companion Diagnostics: Technologies and Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment